Chaozhong Zou, Ph.D
Dr. Zou has many years of extensive CMC product development, product quality control strategy development; tech-transfer; manufacturing and regulatory filing experience in the immune cell therapy field. He has comprehensive experience on transferring a research concept to be a viable cell therapy drug product; with significant contributions, he helped advanced several cell therapy products from preclinical to clinical stages as well as CMC activities for drug commercialization.
Dr. Zou previously was the head of vector and CB analytics at Takeda cell therapy unit, working with CAR-NK/T and iPSC derived cell therapy products; he was an Associate Director at Kite Pharma (Gilead Sciences) working with CAR/TCR based T cell therapy products; he also worked at ATCC as team lead for cell product and process development.
Dr. Zou received his PhD degree from Xiamen University with rich experience on cell cycle and oncology discovery research in academia settings.